Every ESMO trial, ranked by novelty

What to watch at Europe’s biggest cancer conference

Oct 21 • Samuel Hume

5

2

Every breakthrough in medicine in 2026... so far

In cancer, cardiovascular, autoimmunity, neurology, and metabolic.

Oct 15 • Samuel Hume

13

2

1

Every first-in-class drug entering human trials in China this year

All 160 novel programs

Oct 7 • Samuel Hume

11

1

2

September 2026

Do smaller biotechs generate better returns?

Yes they do (but only if backed by specialist investors).

Sep 25 • Samuel Hume

10

1

1

Can we predict the results of clinical trials?

Talking to Thore from Pheiron

Sep 11

9

2

3

A ranking of every biotech company

All 589 companies ranked, using Verdad’s quantitative investment model

Sep 8 • Samuel Hume

10

3

1

August 2026

This week in medicine: daraxonrasib approved, cancer vaccines, heart disease prevention, and more.

Welcome!

Aug 29 • Samuel Hume

14

6

How to make a cancer vaccine

With Dr. Tiffany Ma from Infinitopes

Aug 26 • Samuel Hume

9

2

1

Head of obesity research at Eli Lilly and Verve Therapeutics CEO, Dr. Sekar Kathiresan, on solving heart disease.

The future of cardiovascular disease and obesity.

Aug 22 • Samuel Hume

11

2

1

This week in medicine

A new obesity target, a better way to discover new cancer drug targets, pyroptosis inhibitors for sepsis, an orexin agonist for narcolepsy, and more.

Aug 10 • Samuel Hume

15

1

3

This week in medicine

A hit to the inflammation theory of cardiovascular disease, a non-opioid painkiller, progress for vitiligo, and more.

Aug 2 • Samuel Hume

9

2

3

July 2026

Can AI discover new science?

Finding cancer drug targets with Codex

Jul 28 • Samuel Hume

8

7

4